Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 129
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to...
Psyence and Eden Labs Announce Extraction and Product Development Collaboration
Silo Pharma Announces Stock Repurchase Program
FDA Grants Ehave Consent to Proceed With Its Clinical Study on...
Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical...
Kabir Nath: Our Mission, Progress and Future Perspectives
Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression...
PT385 – Relationships, Conviviality, and The Strength of Empathic Attunement
Kabir Nath: our mission, progress and future perspectives
Late-Stage Psychedelic Trials: A brief review of the two most mature...
Load more